These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
292 related items for PubMed ID: 26495784
1. Efficacy and Safety of Pancrelipase/Pancreatin in Patients With Exocrine Pancreatic Insufficiency and a Medical History of Diabetes Mellitus. Whitcomb DC, Bodhani A, Beckmann K, Sander-Struckmeier S, Liu S, Fuldeore M, Pollack PF, Khurmi RP. Pancreas; 2016; 45(5):679-86. PubMed ID: 26495784 [Abstract] [Full Text] [Related]
7. Pancrelipase delayed-release capsules (CREON) for exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery: A double-blind randomized trial. Whitcomb DC, Lehman GA, Vasileva G, Malecka-Panas E, Gubergrits N, Shen Y, Sander-Struckmeier S, Caras S. Am J Gastroenterol; 2010 Oct; 105(10):2276-86. PubMed ID: 20502447 [Abstract] [Full Text] [Related]
8. Effect of Pancrelipase Therapy on Exocrine Pancreatic Insufficiency Symptoms and Coefficient of Fat Absorption Associated With Chronic Pancreatitis. Barkin JA, Barkin JS. Pancreas; 2021 Feb 01; 50(2):176-182. PubMed ID: 33560089 [Abstract] [Full Text] [Related]
12. A comparison of the efficacy and tolerance of pancrelipase and placebo in the treatment of steatorrhea in cystic fibrosis patients with clinical exocrine pancreatic insufficiency. Stern RC, Eisenberg JD, Wagener JS, Ahrens R, Rock M, doPico G, Orenstein DM. Am J Gastroenterol; 2000 Aug 01; 95(8):1932-8. PubMed ID: 10950038 [Abstract] [Full Text] [Related]
14. Treatment of infants and toddlers with cystic fibrosis-related pancreatic insufficiency and fat malabsorption with pancrelipase MT. Van de Vijver E, Desager K, Mulberg AE, Staelens S, Verkade HJ, Bodewes FA, Malfroot A, Hauser B, Sinaasappel M, Van Biervliet S, Behm M, Pelckmans P, Callens D, Veereman-Wauters G. J Pediatr Gastroenterol Nutr; 2011 Jul 01; 53(1):61-4. PubMed ID: 21694537 [Abstract] [Full Text] [Related]
15. A 51-week, open-label clinical trial in India to assess the efficacy and safety of pancreatin 40000 enteric-coated minimicrospheres in patients with pancreatic exocrine insufficiency due to chronic pancreatitis. Ramesh H, Reddy N, Bhatia S, Rajkumar JS, Bapaye A, Kini D, Kalla M, Thorat V. Pancreatology; 2013 Jul 01; 13(2):133-9. PubMed ID: 23561971 [Abstract] [Full Text] [Related]
16. Randomised clinical trial: a 1-week, double-blind, placebo-controlled study of pancreatin 25 000 Ph. Eur. minimicrospheres (Creon 25000 MMS) for pancreatic exocrine insufficiency after pancreatic surgery, with a 1-year open-label extension. Seiler CM, Izbicki J, Varga-Szabó L, Czakó L, Fiók J, Sperti C, Lerch MM, Pezzilli R, Vasileva G, Pap A, Varga M, Friess H. Aliment Pharmacol Ther; 2013 Apr 01; 37(7):691-702. PubMed ID: 23383603 [Abstract] [Full Text] [Related]
17. Pancreatic enzyme pharmacotherapy. Ferrone M, Raimondo M, Scolapio JS. Pharmacotherapy; 2007 Jun 01; 27(6):910-20. PubMed ID: 17542772 [Abstract] [Full Text] [Related]
19. The effect of oral pancreatic enzyme supplementation on the course and outcome of acute pancreatitis: a randomized, double-blind parallel-group study. Kahl S, Schütte K, Glasbrenner B, Mayerle J, Simon P, Henniges F, Sander-Struckmeier S, Lerch MM, Malfertheiner P. JOP; 2014 Mar 10; 15(2):165-74. PubMed ID: 24618443 [Abstract] [Full Text] [Related]